HRMY
HRMY
US4131971040
Harmony Biosciences Holdings, I
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
2.35B EUR
2.12B EUR
1.62B EUR
2.16B EUR
Enterprise Value
1.8B EUR
1.72B EUR
1.19B EUR
1.57B EUR
Valuation Multiples
Trailing P/E
12.99x
11.67x
11.13x
19.09x
Forward P/E
5.75x
--
--
--
Price to Sales
2.44x
2.2x
1.8x
3.16x
Price to Book
2.34x
2.12x
1.78x
2.48x
EV/Revenue
1.87x
1.79x
1.32x
2.3x
EV/EBITDA
7.03x
6.14x
5.02x
8.35x
Price to FCF (P/FCF)
12.83x
5.96x
4.74x
6.88x
EV/FCF
9.84x
4.85x
3.48x
5x
FCF Yield
7.79%
16.77%
21.09%
14.54%
ende